登录查看更多内容

How can you make biomaterials for drug delivery more cost-effective?

由人工智能和领英社区提供技术支持

Biomaterials are materials that interact with biological systems for medical purposes, such as tissue engineering, wound healing, or drug delivery. Drug delivery is the process of delivering drugs to specific sites in the body to achieve therapeutic effects. Biomaterials can enhance drug delivery by protecting drugs from degradation, targeting specific cells or tissues, releasing drugs in a controlled manner, or modulating the immune response. However, biomaterials for drug delivery also face challenges such as biocompatibility, scalability, cost, and regulatory approval. In this article, you will learn some strategies to make biomaterials for drug delivery more cost-effective without compromising their performance and safety.

在这篇协作文章中查找专家回答

由社区从 6 条内容中精选。了解更多

1 Choose appropriate materials

The choice of materials for biomaterials for drug delivery depends on the type, mode, and duration of drug delivery, as well as the desired biological response. Some common materials include polymers, lipids, proteins, metals, ceramics, and carbon-based materials. Each material has its own advantages and disadvantages in terms of biodegradability, biocompatibility, stability, functionality, and cost. To make biomaterials for drug delivery more cost-effective, you should choose materials that are readily available, easy to process, and suitable for the intended application. For example, you can use natural polymers such as chitosan, alginate, or gelatin, which are derived from renewable sources and have low toxicity and high biodegradability. Alternatively, you can use synthetic polymers such as poly(lactic-co-glycolic acid) (PLGA), poly(ethylene glycol) (PEG), or poly(caprolactone) (PCL), which are versatile, tunable, and widely used for drug delivery.

添加您的观点

Salil Batabyal

Application Specialist | Evident Scientific
举报内容
Selecting Biomaterials for Drug Delivery Precision: The choice of biomaterials for drug delivery hinges on specific criteria such as delivery type, mode, duration, and desired biological response. Options like polymers, lipids, proteins, metals, ceramics, and carbon-based materials each come with distinct attributes. Striking cost-effectiveness involves choosing readily available, easily processable materials aligned with the intended application. Examples include natural polymers (chitosan, alginate, gelatin) from renewable sources, and synthetic polymers (PLGA, PEG, PCL) offering versatility and tunability for drug delivery.

已翻译

赞
Ajith Manayil Parambil, Ph.D.

?? Postdoc @ V?BTUO, Czechia ???? || ?? Visiting Researcher @ Tongji University, China ???? || ?? PhD @ JNU, New Delhi, India ???? || ?? Visiting Researcher @ KMU, Taiwan ???? || DST-INSPIRE??
举报内容
Choosing?suitable materials based on several?criteria is necessary to increase the cost-effectiveness. First, production costs may be significantly decreased?using cheap and readily available raw?materials, such as?alginate or chitosan, which are biodegradable polymers. Selecting materials that can be processed in various?ways, such as compression molding or solution casting, also reduces manufacturing costs. Moreover, adding natural polymers or their derivatives from renewable resources—like starch or cellulose—improves biocompatibility while lowering expenses. Furthermore, large-scale manufacturing at reduced costs per unit is made possible?using scalable synthesis techniques like solvent evaporation or emulsion polymerization.

已翻译

赞

2 Optimize fabrication methods

The fabrication methods for biomaterials for drug delivery involve shaping, modifying, and assembling materials into desired forms and structures, such as nanoparticles, microparticles, microcapsules, hydrogels, scaffolds, or implants. The fabrication methods can affect the size, shape, surface, porosity, mechanical properties, and drug loading and release of biomaterials. To make biomaterials for drug delivery more cost-effective, you should optimize fabrication methods that are simple, scalable, reproducible, and efficient. For example, you can use solvent evaporation, emulsion, or spray drying to produce nanoparticles or microparticles from polymers. You can also use electrospinning, freeze-drying, or 3D printing to create fibrous or porous scaffolds from polymers or ceramics. Moreover, you can use chemical, physical, or biological methods to modify the surface of biomaterials to enhance their stability, functionality, or targeting.

添加您的观点

Salil Batabyal

Application Specialist | Evident Scientific
举报内容
Precision in Biomaterials Fabrication for Drug Delivery: Biomaterial fabrication for drug delivery involves shaping materials into forms like nanoparticles, microparticles, hydrogels, and implants. Fabrication methods impact size, shape, surface, porosity, mechanical properties, and drug attributes. To enhance cost-effectiveness, optimize methods for simplicity, scalability, and efficiency. For instance, use solvent evaporation, emulsion, or spray drying for polymer-based nanoparticles. Employ electrospinning, freeze-drying, or 3D printing for fibrous or porous scaffolds. Modify biomaterial surfaces chemically, physically, or biologically to enhance stability, functionality, or targeting.

已翻译

赞
Ajith Manayil Parambil, Ph.D.

?? Postdoc @ V?BTUO, Czechia ???? || ?? Visiting Researcher @ Tongji University, China ???? || ?? PhD @ JNU, New Delhi, India ???? || ?? Visiting Researcher @ KMU, Taiwan ???? || DST-INSPIRE??
举报内容
Electrospinning or microfluidics may precisely control particle size and shape, reducing material waste and guaranteeing homogeneity. Moreover, employing continuous production instead of batch techniques lowers labor costs and boosts productivity. Furthermore, manufacturing operations are streamlined by utilizing automation, which lowers operational costs and human error. Furthermore, implementing solvent-free or water-based manufacturing techniques and green chemistry principles reduces raw material prices and their adverse environmental effects. Incorporating quality control and in-line monitoring systems also improves process efficiency, lowering the need for post-processing interventions and guaranteeing constant product quality.

已翻译

赞

3 Evaluate performance and safety

The performance and safety of biomaterials for drug delivery depend on their interaction with the biological environment and the drug. The performance and safety of biomaterials for drug delivery can be evaluated by various in vitro and in vivo tests, such as drug loading and release, stability, degradation, cytotoxicity, biocompatibility, biodistribution, pharmacokinetics, pharmacodynamics, and immunogenicity. To make biomaterials for drug delivery more cost-effective, you should evaluate performance and safety in a systematic and rational way, using relevant and reliable models and methods. For example, you can use cell culture, tissue culture, or organ-on-a-chip to mimic the physiological conditions and target organs of drug delivery. You can also use animal models, such as mice, rats, rabbits, or dogs, to simulate the pharmacological and toxicological effects of drug delivery. Furthermore, you can use computational tools, such as mathematical modeling, simulation, or machine learning, to predict and optimize the performance and safety of biomaterials for drug delivery.

添加您的观点

Salil Batabyal

Application Specialist | Evident Scientific
举报内容
Biomaterial Safety and Performance Assessment: Evaluate biomaterials for drug delivery through in vitro and in vivo tests, including drug loading, release, stability, cytotoxicity, and more. Enhance cost-effectiveness with systematic evaluations using relevant models: cell and tissue cultures, organ-on-a-chip, and animal models like mice or rats. Complementarily, leverage computational tools such as mathematical modeling and machine learning to predict and optimize biomaterial performance and safety.

已翻译

赞
Ajith Manayil Parambil, Ph.D.

?? Postdoc @ V?BTUO, Czechia ???? || ?? Visiting Researcher @ Tongji University, China ???? || ?? PhD @ JNU, New Delhi, India ???? || ?? Visiting Researcher @ KMU, Taiwan ???? || DST-INSPIRE??
举报内容
Preclinical research evaluates toxicity profiles, biocompatibility, and effectiveness, which helps select the best biomaterial formulations. In vitro tests are employed to fully characterize drug release kinetics, targeting specificity and tissue responses. This allows for well-informed decisions on material design and formulation techniques. Additionally, using predictive computational models reduces the expense and waste of resources. Furthermore, putting robust quality control procedures in place at every stage of production guarantees uniformity in performance, which lowers the possibility of batch failures and the expenses that come with them. Long-term pharmacokinetic and pharmacodynamic investigations help to minimize side effects.

已翻译

赞

4 Here’s what else to consider

This is a space to share examples, stories, or insights that don’t fit into any of the previous sections. What else would you like to add?

添加您的观点

Materials Science

+ 关注

给文章评分

我们借助人工智能创建了此文章。您认为这篇文章怎么样？

很棒不太好

举报此文章

查看全部

How can you make biomaterials for drug delivery more cost-effective?

1

2

3

4

1 Choose appropriate materials

2 Optimize fabrication methods

3 Evaluate performance and safety

4 Here’s what else to consider

Materials Science

给文章评分

感谢您的反馈

更多Materials Science相关文章

更多相关阅读内容